The founder and CEO of Canopy Growth has apologized to customers over a medical marijuana recall that forced Health Canada to introduce spot checks for banned pesticides at licensed production facilities.
The apology is aimed at customers who bought medical marijuana from the Toronto-based company Mettrum. Canopy Growth took over Mettrum on Feb. 1.
In an email sent Thursday to Mettrum customers, Bruce Linton said new quality assurance practices are now in place.
‘I’m sorry you had to go through this’
“I’m sorry you had to go through this. And I will do my best to ensure it doesn’t happen again,” he wrote in the email seen by CBC News.
The voluntary recall over pot tainted with pesticides at Mettrum — the second-largest licensed medical marijuana producer in Canada — affected 21,000 customers across the country.
A month ago, Mettrum recalled all of its products produced between Jan. 1, 2016, and March 21, 2016, after small amounts of myclobutanil were discovered.
Myclobutanil is a fungicide approved for use on food crops, but it’s banned for marijuana and tobacco. When heated, myclobutanil converts to hydrogen cyanide.
Linton’s email said the myclobutanil amounts were “trace amounts” and prompted a type three recall.
Health Canada defines that as a situation in which using a product is not likely to cause any adverse health consequences.
According to Health Canada, hydrogen cyanide exposure can cause headaches, dizziness, nausea and vomiting. Larger concentrations may cause gasping, irregular heartbeats, seizures, fainting and even death.
In November 2016, Mettrum also pulled some cannabis products when pyrethrin, another unapproved pest-control product, was detected.
In December, Mettrum expanded its recall and withdrew a small number of additional marijuana products. A…